Mxbbb Announces Nationwide Voluntary Recall of Umary Acid Hyaluronic Over Concerns of Diclofenac and Omeprazole Contamination

Overview

Recall Announcement

MXBBB is voluntarily recalling one lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG. Testing has revealed that the product contains omeprazole and diclofenac. The FDA’s laboratory analysis confirms these findings.

Risk Statement: Diclofenac is classified as a non-steroidal anti-inflammatory drug (NSAID), which may elevate the risk of cardiovascular issues such as heart attacks and strokes, alongside severe gastrointestinal complications including bleeding, ulcers, and potential perforations in the stomach and intestines. The undisclosed inclusion of this ingredient may also interact with other medications, raising the risk of severe adverse events, especially when combined with other NSAID-containing products. Omeprazole, a proton pump inhibitor (PPI) used for managing gastric acid conditions, carries risks such as significant skin reactions, abdominal discomfort, diarrhea, nausea, and headaches. This unlisted ingredient may conceal gastrointestinal concerns such as erosion, ulcers, and stomach cancer, and should not be taken with certain other medications. Currently, MXBBB has not received reports of adverse events relating to this recall.

The UMARY product has been distributed nationwide via Amazon.

Used as a dietary supplement, the product is packaged in a plastic container. The affected lot of UMARY Hyaluronic Acid has the UPC: 7502265120323, which includes Lot number: 24183 and an expiration date of: 07/01/24. A total of 321 units were distributed.

MXBBB is informing distributors and customers through Amazon and is organizing the return of all recalled items. Customers who possess the recalled Umary product should cease usage and return it to the point of purchase for a full refund. For any concerns regarding side effects potentially related to the usage of this product, consumers are advised to consult their healthcare provider.

For inquiries about this recall, consumers may reach out to MXBBB by calling (915) 259-6936 or via email at Joshua980810@outlook.com any time.

Adverse reactions or any quality issues experienced with this product can be reported to the FDA’s MedWatch Adverse Event Reporting program online, or via regular mail or fax.

• To report online, complete the form here.
• For reporting via Mail or Fax: Download the form or call 1-800-332-1088 to request one. Complete and return it to the pre-addressed address, or send it via fax to 1-800-FDA-0178.

This recall is initiated with the awareness of the U.S. Food and Drug Administration.

For more details, visit the FDA Advisory page.